Ohmline Drug Delivery Platform.

Focused on biotechnology and nanomedicine innovation, Lifesome Therapeutics provides a unique bioactive lipid platform for researchers, CROs, CMOs, and pharmaceutical developers.

Based on a single lipid component with intrinsic therapeutic activity and the ability to self-assemble into different supramolecular structures, the platform offers new opportunities for drug development, in vivo validation, and toxicity assessment studies.

Designed for applications in oncology and infectious diseases, Lifesome’s technology enables the exploration of novel therapeutic strategies and the development of next-generation products combining delivery capabilities with intrinsic biological activity.